Semaglutide
All Inclusive Treatment Plan

1. Prequalify: Be 18 years old+. Have a Body mass index (BMI) of 27+ and no known contraindications.
2. Make Payment: Choose your treatment, place your order, and submit payment.
3. Complete Medical History Intake: Complete a patient forms.
4. Telehealth Appointment: Connect with your healthcare provider through a telehealth (audio-visual) appointment. The doctor will review your medical history and determine if Semaglutide or Tirzepitide is a suitable weight loss treatment.
5. Receive Medication: Your medication will be delivered to the doorstep of the address provided, eliminating the need to leave home or travel to a pharmacy.

Yes! Our program is all-inclusive:

Includes:

• Online Doctor Consultation
• Weightloss Treatment Plan
• Prescription for Semaglutide
• Free Delivery
• Comfort Of Your Home
• All Supplies That Are Required
• Instructions

It depends on the package you choose. 

Choose either:

1. 1 Month: $399
2. 3 Months: $999 (save $198)

• Comprehensive safety information outlining potential side effects
• Usage instructions
• Important health considerations

Yes. All Semaglutide Scripts are sent in an unmarked package to maintain your privacy.

Yes, all Semaglutide Script orders require a medical provider’s prescription. 

Yes, Absolutely! We prioritize your privacy. All consultations are confidential and comply with HIPAA and HITECH regulations, ensuring your personal and medical information is securely encrypted.

Semaglutide Script consultations are conducted virtually. Here is how it works:

• Schedule appointment: With a U.S. licensed medical provider
• Choose Your Semaglutide Treatment Plan: Either 1 or 3 months supply of medication
• Submit Payment: Online (call or text us)
• Follow Instructions: Sent via text or email
• Weight Loss Consultation: Discuss your health goals and medical history to determine if Semaglutide is appropriate
• Semaglutide Prescription: Our medical provider will send your prescription to the pharmacy
• Receive Semaglutide: Your medication will be delivered to the address you provided

When a person’s BMI is between 27 and 30, they may qualify for Semaglutide treatment if they have at least one of the following weight-related conditions:

1. Type 2 Diabetes
2. Hypertension (High Blood Pressure)
3. Dyslipidemia (High Cholesterol)
4. Obstructive Sleep Apnea
5. Cardiovascular Disease (such as coronary artery disease)
6. Insulin Resistance (including conditions like prediabetes or metabolic syndrome)
7. Non-Alcoholic Fatty Liver Disease (NAFLD)
8. Osteoarthritis (linked to excess weight)
9. Polycystic Ovary Syndrome (PCOS)
10. Gastroesophageal Reflux Disease (GERD)

These conditions, combined with a BMI in the 27-30 range, are used to determine eligibility for weight-loss treatments like Semaglutide.

• Personal or Family History of Medullary Thyroid Carcinoma (MTC): Semaglutide carries a risk of thyroid C-cell tumors, including MTC, based on animal studies, though this hasn’t been
  • Gallbladder Disease: Semaglutide may increase the risk of gallbladder-related issues, such as cholelithiasis (gallstones) and cholecystitis (inflammation of the gallbladder). Patients with a history of gallbladder disease should be monitored closely while on semaglutide.
• Kidney Disease: There have been reports of acute kidney injury and worsening of chronic kidney disease in patients taking semaglutide. While the exact cause is not fully understood, it may be related to dehydration, nausea, or vomiting that sometimes occurs as side effects of the medication. Patients with renal impairment should be monitored for changes in kidney function.
• Diabetic Retinopathy: In clinical trials, patients with pre-existing diabetic retinopathy who were taking semaglutide experienced a worsening of their condition more often than those who were not taking the drug. Caution is advised for individuals with this condition, and regular eye exams should be performed.
• Heart Rate Increase: Semaglutide has been associated with a slight increase in heart rate. Though the clinical significance of this is not fully understood, individuals with a history of heart disease or arrhythmias should be monitored for changes in heart rate while taking the medication.
• Pancreatic Issues: As mentioned earlier, semaglutide has been associated with an increased risk of pancreatitis. Those with a history of pancreatic issues should be cautious and report any symptoms such as severe abdominal pain, nausea, or vomiting.
• Depression and Suicidal Thoughts: Although rare, some patients have reported experiencing depression, mood changes, or suicidal thoughts while taking semaglutide. This is more of a concern for individuals with a history of mental health disorders, and they should be monitored closely.
• Hypoglycemia (Low Blood Sugar): While semaglutide itself does not cause hypoglycemia, it can increase the risk of low blood sugar when used in combination with insulin or other antidiabetic medications like sulfonylureas. This is a particular concern for individuals who are on a combination of therapies that lower blood glucose.
• Severe Allergic Reactions: Although not common, some patients have reported serious allergic reactions, including anaphylaxis, angioedema, and skin reactions such as urticaria (hives). Individuals with a history of severe allergic reactions should be cautious.
• Pregnancy: Avoid using Semaglutide at least two months prior to planning a pregnancy.

1. Nausea Management: Semaglutide, a GLP-1 receptor agonist, can cause gastrointestinal side effects, including nausea and vomiting. Pyridoxine has been used as an adjunct to reduce nausea in various settings, such as pregnancy-related nausea. It might help alleviate mild nausea associated with semaglutide therapy.
2. Metabolic Support: Semaglutide affects glucose metabolism and helps improve insulin sensitivity. Pyridoxine supports overall metabolic health by aiding in the metabolism of proteins, fats, and carbohydrates, which may contribute to optimizing the overall effects of semaglutide.
3. Neuropathy Prevention: Long-term diabetes and obesity can lead to peripheral neuropathy. Vitamin B6 is essential for maintaining nerve function, and ensuring adequate levels might help mitigate the risk of neuropathy, particularly in patients with diabetes undergoing weight loss with semaglutide.
4. Energy Levels: Some patients on semaglutide might feel fatigued due to dietary changes or reduced caloric intake. Pyridoxine supports energy metabolism by helping convert food into energy, which could assist patients in maintaining energy levels during weight loss efforts.